Log inSign up
Lantern Pharma
668 posts
Lantern Pharma profile banner
@LanternPharma

Lantern Pharma

@LanternPharma
Leveraging A.I. to develop, revitalize, & rescue drugs for oncology. (Nasdaq : LTRN)
DALLAS & PLANO, TEXAS - USA
lanternpharma.com
Joined June 2015
361
Following
736
Followers
RepliesRepliesRepostsRepostsMediaMedia

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
  • @LanternPharma
    Lantern Pharma
    @LanternPharma
    Aug 13
    Happening TOMORROW - @LanternPharma 2nd Quarter 2026 Earnings call - register now to join us tomorrow at 9AM Eastern Time. 🔗Register Now: bit.ly/4g79Qfo $LTRN
    Image
    us06web.zoom.us
    Video Conferencing, Web Conferencing, Webinars, Screen Sharing
    Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom...
  • @LanternPharma
    Lantern Pharma
    @LanternPharma
    Aug 12
    Getting ready for our Open-Medicine AI launch and scale up. This is a major need for our drug development community. Excited to be a part of this massively important mission and launch. (open-medicine.ai)
    Image
  • @LanternPharma
    Lantern Pharma
    @LanternPharma
    Aug 12
    Join us this Friday for @LanternPharma's Q2 2026 Operating & Financial Results Webcast. Management will discuss: 🔹 Q2 operating & financial results 🔹 Upcoming milestones 🔹 RADR & Open-Medicine AI developments 🕘 Aug. 14 | 9:00 AM ET Register now: bit.ly/4g79Qfo $LTRN
    Image
  • @LanternPharma
    Lantern Pharma
    @LanternPharma
    Jun 22
    Join Lantern Pharma during #BIO2026 for an executive roundtable hosted by @Polsinelli . Featuring CEO Panna Sharma, Moderated by Matt Murer 📅 June 23 🕗 8:00–10:00 AM PT RSVP NOW: bit.ly/4uFxDsi $LTRN
    Image
  • @LanternPharma
    Lantern Pharma
    @LanternPharma
    Jun 2
    New HARMONIC™ data continue to strengthen the LP-300 story in EGFR exon 21 L858R never-smoker NSCLC: 📈 8.9-month mPFS 📈 77% CBR The updated dataset is supporting partnering discussions at #ASCO26. Full release: bit.ly/4ejc4st $LTRN
    Image
Advertisement
Advertisement